131 related articles for article (PubMed ID: 27449629)
1. Itraconazole-loaded nanostructured lipid carriers (NLC) for pulmonary treatment of aspergillosis in falcons.
Pardeike J; Weber S; Zarfl HP; Pagitz M; Zimmer A
Eur J Pharm Biopharm; 2016 Nov; 108():269-276. PubMed ID: 27449629
[TBL] [Abstract][Full Text] [Related]
2. Development of an itraconazole-loaded nanostructured lipid carrier (NLC) formulation for pulmonary application.
Pardeike J; Weber S; Haber T; Wagner J; Zarfl HP; Plank H; Zimmer A
Int J Pharm; 2011 Oct; 419(1-2):329-38. PubMed ID: 21839157
[TBL] [Abstract][Full Text] [Related]
3. A model for treating avian aspergillosis: serum and lung tissue kinetics for Japanese quail (Coturnix japonica) following single and multiple aerosol exposures of a nanoparticulate itraconazole suspension.
Rundfeldt C; Wyska E; Steckel H; Witkowski A; Jeżewska-Witkowska G; Wlaź P
Med Mycol; 2013 Nov; 51(8):800-10. PubMed ID: 23815436
[TBL] [Abstract][Full Text] [Related]
4. Miconazole-loaded nanostructured lipid carriers (NLC) for local delivery to the oral mucosa: improving antifungal activity.
Mendes AI; Silva AC; Catita JA; Cerqueira F; Gabriel C; Lopes CM
Colloids Surf B Biointerfaces; 2013 Nov; 111():755-63. PubMed ID: 23954816
[TBL] [Abstract][Full Text] [Related]
5. Nanostructured lipid carriers as delivery system for the phopholipase A2 inhibitors PX-18 and PX-13 for dermal application.
Pardeike J; Schmidt C; Volz I; Müller RH
Pharmazie; 2011 May; 66(5):357-61. PubMed ID: 21699069
[TBL] [Abstract][Full Text] [Related]
6. A novel oral delivery system consisting in "drug-in cyclodextrin-in nanostructured lipid carriers" for poorly water-soluble drug: vinpocetine.
Lin C; Chen F; Ye T; Zhang L; Zhang W; Liu D; Xiong W; Yang X; Pan W
Int J Pharm; 2014 Apr; 465(1-2):90-6. PubMed ID: 24530388
[TBL] [Abstract][Full Text] [Related]
7. Development and characterization of itraconazole-loaded solid lipid nanoparticles for ocular delivery.
Mohanty B; Majumdar DK; Mishra SK; Panda AK; Patnaik S
Pharm Dev Technol; 2015 Jun; 20(4):458-64. PubMed ID: 24490828
[TBL] [Abstract][Full Text] [Related]
8. Nanostructured lipid carriers as novel drug delivery system for lung cancer gene therapy.
Han Y; Li Y; Zhang P; Sun J; Li X; Sun X; Kong F
Pharm Dev Technol; 2016; 21(3):277-81. PubMed ID: 25560648
[TBL] [Abstract][Full Text] [Related]
9. In vivo efficacy of aerosolized nanostructured itraconazole formulations for prevention of invasive pulmonary aspergillosis.
Hoeben BJ; Burgess DS; McConville JT; Najvar LK; Talbert RL; Peters JI; Wiederhold NP; Frei BL; Graybill JR; Bocanegra R; Overhoff KA; Sinswat P; Johnston KP; Williams RO
Antimicrob Agents Chemother; 2006 Apr; 50(4):1552-4. PubMed ID: 16569882
[TBL] [Abstract][Full Text] [Related]
10. Nanostructured lipid carriers as novel carrier for parenteral delivery of docetaxel.
Liu D; Liu Z; Wang L; Zhang C; Zhang N
Colloids Surf B Biointerfaces; 2011 Jul; 85(2):262-9. PubMed ID: 21435845
[TBL] [Abstract][Full Text] [Related]
11. Encapsulation of ascorbyl palmitate in nanostructured lipid carriers (NLC)--effects of formulation parameters on physicochemical stability.
Teeranachaideekul V; Müller RH; Junyaprasert VB
Int J Pharm; 2007 Aug; 340(1-2):198-206. PubMed ID: 17482778
[TBL] [Abstract][Full Text] [Related]
12. Formulation development of itraconazole PEGylated nano-lipid carriers for pulmonary aspergillosis using hot-melt extrusion technology.
Shadambikar G; Marathe S; Ji N; Almutairi M; Bandari S; Zhang F; Chougule M; Repka M
Int J Pharm X; 2021 Dec; 3():100074. PubMed ID: 33748741
[TBL] [Abstract][Full Text] [Related]
13. Formation of a physical stable delivery system by simply autoclaving nanostructured lipid carriers (NLC).
Pardeike J; Weber S; Matsko N; Zimmer A
Int J Pharm; 2012 Dec; 439(1-2):22-7. PubMed ID: 22989983
[TBL] [Abstract][Full Text] [Related]
14. Itraconazole lipid nanocapsules gel for dermatological applications: In vitro characteristics and treatment of induced cutaneous candidiasis.
El-Sheridy NA; Ramadan AA; Eid AA; El-Khordagui LK
Colloids Surf B Biointerfaces; 2019 Sep; 181():623-631. PubMed ID: 31202972
[TBL] [Abstract][Full Text] [Related]
15. Formulating fluticasone propionate in novel PEG-containing nanostructured lipid carriers (PEG-NLC).
Doktorovová S; Araújo J; Garcia ML; Rakovský E; Souto EB
Colloids Surf B Biointerfaces; 2010 Feb; 75(2):538-42. PubMed ID: 19879736
[TBL] [Abstract][Full Text] [Related]
16. Chlorogenic acid stabilized nanostructured lipid carriers (NLC) of atorvastatin: formulation, design and in vivo evaluation.
Khan S; Baboota S; Ali J; Narang RS; Narang JK
Drug Dev Ind Pharm; 2016; 42(2):209-20. PubMed ID: 26016780
[TBL] [Abstract][Full Text] [Related]
17. Characterization of indomethacin-loaded lipid nanoparticles by differential scanning calorimetry.
Castelli F; Puglia C; Sarpietro MG; Rizza L; Bonina F
Int J Pharm; 2005 Nov; 304(1-2):231-8. PubMed ID: 16188405
[TBL] [Abstract][Full Text] [Related]
18. The use of voriconazole for the treatment of aspergillosis in falcons (Falco species).
Di Somma A; Bailey T; Silvanose C; Garcia-Martinez C
J Avian Med Surg; 2007 Dec; 21(4):307-16. PubMed ID: 18351011
[TBL] [Abstract][Full Text] [Related]
19. Nanostructured lipid carriers as semisolid topical delivery formulations for diflucortolone valerate.
Abdel-Salam FS; Mahmoud AA; Ammar HO; Elkheshen SA
J Liposome Res; 2017 Mar; 27(1):41-55. PubMed ID: 26956098
[TBL] [Abstract][Full Text] [Related]
20. Effect of surfactant on lycopene-loaded nanostructured lipid carriers.
Riangjanapatee P; Okonogi S
Drug Discov Ther; 2012 Jun; 6(3):163-8. PubMed ID: 22890207
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
